TLX Stock Analysis: Talanx | XETRA
Insurance - Diversified | XETRA, Germany | Market Cap: 34.293m EUR | 12M Return: 20.8% | DE000TLX1005 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.3M
EPS Trend: 92.7%
Rev. Trend: 91.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Talanx AG is a Germany-based global insurance group that operates across both life and non-life insurance, as well as reinsurance, with products spanning motor, property, casualty, health, aviation, marine, credit, and specialty lines such as cyber and parametric cover. The company also runs asset management and bancassurance activities, distributing products through retail, corporate, and partnership channels. Founded in 1903 and headquartered in Hanover, Talanx is majority-owned by HDI Haftpflichtverband der Deutschen Industrie V.a.G., giving it a mutual-style controlling shareholder structure that is common among large European insurers. Its operations span more than 150 countries, with a particularly strong footprint in Germany, the UK, Central and Eastern Europe, and the Americas, supporting a globally diversified premium base.
- Hannover Re reinsurance pricing strengthens on hard market cycle
- Catastrophe losses weigh on combined ratios across segments
- Rising interest rates lift investment income and underwriting margins
| Net Income: 2.71b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.45 > 1.0 |
| NWC/Revenue: 40.28% < 20% (prev 30.44%; Δ 9.84% < -1%) |
| CFO/TA 0.04 > 3% & CFO 8.37b > Net Income 2.71b |
| Net Debt (3.58b) to EBITDA (18.8b): 0.19 < 3 |
| Current Ratio: -1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (258.2m) vs 12m ago 0.0% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 30.84% > 50% (prev 14.06%; Δ 16.79% > 0%) |
| Interest Coverage Ratio: 78.98 > 6 (EBIT TTM 18.6b / Interest Expense TTM 236.0m) |
| A: 0.12 (Total Current Assets 13.8b - Total Current Liabilities -8.92b) / Total Assets 187b |
| B: 0.07 (Retained Earnings 12.3b / Total Assets 187b) |
| C: 0.10 (EBIT TTM 18.6b / Avg Total Assets 183b) |
| D: 0.09 (Book Value of Equity 14.9b / Total Liabilities 164b) |
| Altman-Z'' = 1.79 = BBB |
As of November 14, 2026, the stock is trading at EUR 133.20 with a total of 114,872 shares traded. Over the past week, the price has changed by +2.54%, over one month by +8.47%, over three months by +16.33% and over the past year by +20.78%.
Current recommended Stop Loss: 129.90 (which is 2.5% or 1.4 ATR below the current price).
Talanx has no consensus analysts rating.
P/E Trailing = 13.1746
P/E Forward = 11.0742
P/S = 0.8064
P/B = 2.3449
P/EG = 3.4608
Revenue TTM = 56.5b EUR
EBIT TTM = 18.6b EUR
EBITDA TTM = 18.8b EUR
Long Term Debt = 7.90b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.73b EUR (from shortTermDebt, last fiscal year)
Debt = 8.84b EUR (from shortLongTermDebtTotal, last fiscal year) + Leases 367.0m
Net Debt = 3.58b EUR (calculated: Debt 8.84b - CCE 5.26b)
Enterprise Value = 37.9b EUR (34.3b + Debt 8.84b - CCE 5.26b)
Interest Coverage Ratio = 78.98 (Ebit TTM 18.6b / Interest Expense TTM 236.0m)
EV/FCF = 4.78x (Enterprise Value 37.9b / FCF TTM 7.92b)
FCF Yield = 20.91% (FCF TTM 7.92b / Enterprise Value 37.9b)
FCF Margin = 14.03% (FCF TTM 7.92b / Revenue TTM 56.5b)
Net Margin = 4.80% (Net Income TTM 2.71b / Revenue TTM 56.5b)
Gross Margin = unknown ((Revenue TTM 56.5b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.20 (Enterprise Value 37.9b / Total Assets 187b)
Interest Expense / Debt = 2.67% (Interest Expense 236.0m / Debt 8.84b)
Taxrate = 7.45% (1.37b / 18.3b)
NOPAT = 17.3b (EBIT 18.6b * (1 - 7.45%))
Current Ratio = unknown (Total Current Assets 13.8b / Total Current Liabilities -8.92b)
Debt / Equity = 0.59 (Debt 8.84b / totalStockholderEquity, last quarter 14.9b)
Debt / EBITDA = 0.19 (Net Debt 3.58b / EBITDA 18.8b)
Debt / FCF = 0.45 (Net Debt 3.58b / FCF TTM 7.92b)
Total Stockholder Equity = 10.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.48% (Net Income 2.71b / Total Assets 187b)
RoE = 25.33% (Net Income TTM 2.71b / Total Stockholder Equity 10.7b)
RoCE = 100.2% (EBIT 18.6b / Capital Employed (Equity 10.7b + L.T.Debt 7.90b))
RoIC = 9.80% (EBIT 18.6b / (Assets 187b - Curr.Liab -8.92b - Cash 5.26b))
WACC = 5.01% (E(34.3b)/V(43.1b) * Re(5.66%) + D(8.84b)/V(43.1b) * Rd(2.67%) * (1-Tc(0.07)))
Discount Rate = 5.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 34.82 | Cagr: 0.0%
[DCF] Terminal Value 74.57% ; FCFF base≈8.12b ; Y1≈7.74b ; Y5≈7.39b
[DCF] Fair Price = 436.1 (EV 116b - Net Debt 3.58b = Equity 113b / Shares 258.2m; r=8.35% [WACC [floored]]; 5y FCF grow -6.08% → 2.50% )
EPS Correlation: 92.73 | EPS CAGR: 18.43% | SUE: N/A | # QB: 0
Revenue Correlation: 91.44 | Revenue CAGR: 72.01% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.77 | Chg30d=-5.95% | Revisions=-25% | Analysts=2
EPS next Quarter (2027-03-31): EPS=2.90 | Chg30d=+2.11% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=11.07 | Chg30d=-0.46% | Revisions=-17% | GrowthEPS=+15.3% | GrowthRev=+1.5%
EPS next Year (2027-12-31): EPS=11.70 | Chg30d=+1.21% | Revisions=+17% | GrowthEPS=+5.7% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +0% (up=4, down=4)